A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

In Vitro Imaging and Quantification of the Drug Targeting Efficiency of Fluorescently Labeled GnRH Analogues

7.2K views

⸱

DOI:

10.3791/55529

⸱

March 21st, 2017

 ,  ,  ,  ,  , 

In This Article

Summary

Selectively labeled fluorescent GnRH-I, -II and -III derivatives are reliable tools for tracking and quantifying their cellular uptake. This manuscript introduces experiments to visualize, quantify and compare the uptake efficiency of these GnRH conjugates in various cell lines.

Abstract

GnRH analogues are effective targeting moieties and able to deliver anticancer agents selectively into malignant tumor cells which highly express GnRH receptors. However, the quantitative analysis of GnRH analogues' cellular uptake and the investigated cell types in GnRH-based drug delivery systems are currently limited. Previously introduced, selectively labeled fluorescent GnRH I, -II and -III derivatives provide great detectability, and they have suitable chemical properties for reproducible and robust experiments. We also found that the appropriate up-to-date methods with these labeled GnRH analogues could offer novel information about the GnRH-based drug delivery systems. This manuscript introduces some simple and fast experiments regarding the cellular uptake of [D-Lys6(FITC)]-GnRH-I, [D-Lys6(FITC)]-GnRH-II and [Lys8(FITC)]-GnRH-III on the EBC-1 (lung), the BxPC-3 (pancreas) and on the Detroit-562- (pharynx) malignant tumor cells. In parallel with these GnRH-FITC conjugates, the cell surface level of GnRH-I receptors was also examined on these cell lines before and after the GnRH treatment by confocal laser scanning microscopy. The cellular uptake of GnRH-FITC conjugates was quantified by fluorescence-activated cell sorting. In these experiments minor differences among GnRH analogues and major differences among cell types was observed. The significant differences among cell lines are correlated with their distinct level of cell surface GnRH-I receptors. The introduced experiments contain practical methods to visualize, quantify and compare the uptake efficiency of GnRH-FITC conjugates in a time- and concentration-dependent manner on various adherent cell cultures. These results could predict the drug targeting efficiency of GnRH conjugates on the given cell culture, and offer a good basis for further experiments in the examination of GnRH-based drug delivery systems.

Introduction

Peptide based targeted drug delivery systems have become a fast developing and promising area in cancer therapy over the past few years1,2. Human gonadotropin releasing hormone receptor type I (GnRH-I-R) is primarily located in the pituitary gland but is also present in several other tissues which are responsible for self-reproduction3. GnRH-I-R is also expressed in a number of cancer tissues, related or unrelated to the reproductive system4,5. The high expression of GnRH-I-R on several malignant tumor cells compared with health....

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Preparation of Cell Cultures and Reagents

  1. Maintain the cell cultures in the manufacturer's recommended medium, supplemented with 10% (v/v) fetal bovine serum and antibiotics (called complete medium). Keep the cell culturing flask in a humidified, 5% CO2 atmosphere incubator at 37 °C. Follow the proliferation and confluency of cells by inverted microscope (using 10X phase contrast objective).
  2. When cells reach adequate confluency, remove the medium, and wash the culture with 2-3 mL, sterile phosphate-buffered saline (PBS). Remove the PBS and add 0.5 mL, sterile 0.25% trypsin-EDTA solution to the cell culture and incubate at 3....

Access restricted. Please log in or start a trial to view this content.

Results

Images obtained by confocal laser scanning microscopy (CLSM) offer spectacular information about the uptake of GnRH-FITC conjugates on the given cell culture in a time and concentration dependent manner. In parallel with these GnRH-FITC conjugates, the presence of the GnRH-I-R on the cell surface is also verifiable by the CLSM experiment. Furthermore, by using a far-red DNA staining fluorescent probe, it is possible to counterstain the nuclei of cells besides GnRH and GnRH-I-R. However, w.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Experiments described herein use selectively labeled GnRH analogues for screening adherent cell cultures in vitro. Confocal microscopy and flow cytometry methods are suitable for tracking and quantifying the cellular uptake of these GnRH-FITC conjugates in a time and concentration dependent manner. These experiments have the following critical steps: 1) maintain a sterile, healthy cell culture; 2) GnRH peptides must be of high quality; 3) reasonable concentrations and incubation times must be followed; .......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

The project was supported by National Research Fund OTKA (K 104045).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
EBC-1JCRB Cell BankJCRB0820Human lung squamous cell carcinoma
BxPC-3ATCCCRL-1687Human pancreatic adenocarcinoma
Detroit-562ATCCCCL-138Human pharyngeal carcinoma
RPMI-1640 Medium with L-glutamineLonzaBE12-702FCulture medium for BxPC-3 cells
Eagle's Minimum Essential MediumLonzaBE12-611FCulture medium for EBC-1 cells, and complemented with 0.1% sodium pyruvate for Detroit-562 cells
Fetal Bovine SerumEuro CloneECS0180LComplements the culture medium
MycoZap Plus-CL LonzaVZA-2012Complements the culture medium (antibiotics)
Standard Line Cell Culture FlasksVWR10062-872Provide consistent, sterile growth environment for cells
Trypsin-EDTA Mixture LonzaBE17-161ERemove attached cells
Phosphate Buffered Saline (PBS)LonzaBE17-516FSolvent
Dimethyl sulfoxideSigma-AldrichD8418-100MLSolvent
Trypan Blue Solution, 0.4%Thermo Fisher Scientific15250061Used to counting cells
[D-Lys6(FITC)]-GnRH-Imade by us-Purity ≥98% (HPLC)
[D-Lys6(FITC)]-GnRH-IImade by us-Purity ≥98% (HPLC)
[Lys8(FITC)]-GnRH-IIImade by us-Purity ≥98% (HPLC)
glass bottom 8-well microscopic slideIbidi80826Use in CLSM experiment
Corning Costar cell culture plate, 12 wellSigma-AldrichCLS3513-50EAUse in FACS experiment
Fixing solution (10% neutral buffered formalin)Bio-Optica01V60PFix adherent cells
Bovine Serum AlbuminSigma-AldrichA7906-10GPrevent the nonspecific binding of the antibodies
GnRHR AntibodyProteintech19950-1-APImmunocytochemistry reagent, bind to the human type-I GnRH receptors
Secondary Antibody, Alexa Fluor 546 conjugateThermo Fisher ScientificA11035Immunocytochemistry reagent, bind to the primary antibody
Fluorescent probe solution (Draq5)Thermo Fisher Scientific62254Counterstain nuclei
Fluoromount Aqueous Mounting MediumSigma-AldrichF4680-25MLUse in CLSM experiment, preserving fluorescence
Inverted microscopeElektro-Optika Ltd. Alpha XDS-2TCheck the phenotype and confluency of cell cultures
Inverted confocal laser scanning microscopeZeissLSM-710Use in CLSM experiment
Flow cytometerBD BiosciencesBD FACSCaliburUse in FACS experiment

References

  1. Gilad, Y., Firer, M., Gellerman, G. Recent Innovations in Peptide Based Targeted Drug Delivery to Cancer Cells. Biomedicines. 4 (2), 11(2016).
  2. Majumdar, S., Siahaan, T. J. Peptide-mediated targeted drug delivery. Med Res Rev. 32 (3), 637-658 (2012).
  3. Ramakrishnappa, N., Rajamahendran, R., Lin, Y. M., Leung, P. C. K.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Fluorescent LabelingConfocal MicroscopyFlow CytometryCellular UptakeCancer Cell LinesGnRH ReceptorsFluorescence QuantificationTime Concentration Dependent